Skip to content

Belotecan

ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS

Also known as: belotecan hydrochloride, camtobell, CKD-602, CKD602

Korean Food and Drug Administration (KFDA) approvedATC L01CE04

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Belotecan is a drug catalogued in DrugCentral. It was first approved by the Korean Food and Drug Administration (KFDA) in 2003. DrugCentral lists 1 molecular target, including TOP1. Recorded indications include Malignant tumor of ovary and Non-small cell lung cancer.

  • Molecular targets: TOP1 (1 listed in DrugCentral).
  • Indications: Malignant tumor of ovary and Non-small cell lung cancer.
  • ATC code: L01CE04 (Topoisomerase 1 (TOP1) inhibitors).
  • Molecular formula: C25H27N3O4; molecular weight 433.51 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (2)

  • Malignant tumor of ovary
  • Non-small cell lung cancer

Mechanism & targets

Molecular targets (1)

TargetGeneActionActivity
DNA topoisomerase 1TOP1inhibitorIC50 6.56

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
2003-12-10Korean Food and Drug Administration (KFDA)—Chong Kun Dang

ATC classification

ATC codeTherapeutic hierarchy
L01CE04ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS › ANTINEOPLASTIC AGENTS › PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS › Topoisomerase 1 (TOP1) inhibitors

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Belotecan is on its molecule page.

Molecular formulaC25H27N3O4
Molecular weight433.51 g/mol
CAS number256411-32-2
InChIKeyLNHWXBUNXOXMRL-VWLOTQADSA-N
PubChem CID6456014
CC[C@@]1(O)C(=O)OCC2=C1C=C1N(CC3=C(CCNC(C)C)C4=CC=CC=C4N=C13)C2=O

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Belotecan used for?

DrugCentral lists the following indications for Belotecan: Malignant tumor of ovary and Non-small cell lung cancer.

How does Belotecan work?

Its molecular targets in DrugCentral include TOP1 (inhibitor).

When was Belotecan first approved?

Belotecan was first approved by the Korean Food and Drug Administration (KFDA) in 2003.

What is the chemical formula of Belotecan?

Belotecan has the molecular formula C25H27N3O4 and a molecular weight of 433.51 g/mol.

Browse: all drugs starting with B · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval2003-12-10
AgencyKorean Food and Drug Administration (KFDA)
Targets1
Indications2
FormulaC25H27N3O4
DrugCentral ID296
Interactive profile